Comment on ‘Transitioning to Intravitreal Aflibercept Following a Previous Treat-And-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: 24-Month Results’

Eye - United Kingdom
doi 10.1038/eye.2015.190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy